The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Proactive Pharmaceutical Care Interventions Improve Patients’ Adherence to Lipid-Lowering Medication
Abstract
Bachground: Lipid-lowering drugs are effective preventive medication for patients at risk of cardiovascular complications. However, medication adherence is suboptimal, thereby decreasing therapy effectiveness. Pharmaceutical care interventions may increase therapy adherence. Objective: To assess the effect of a proactive pharmaceutical care intervention program, Medication Monitoring and Optimization (MeMO), on therapy discontinuation and adherence with lipid-lowering drugs as well as patients’ satisfaction with the intervention program. Methods: This prospective intervention study included 1002 patients initiating lipid-lowering drug therapy from 9 Dutch community pharmacies. In the intervention group (n = 500), the MeMO program was used, comprising continuous monitoring of patients’ adherence to lipid-lowering drugs and personal counseling with nonadherent patients. The intervention group was compared with a historical reference group (n = 502) receiving usual care. Outcomes were therapy discontinuation and adherence. Results: Discontinuation rates with lipid lowering drugs in the first year after drug initiation were 13.6% for the intervention group and 25.9% in the usual care group; continued but non-adherent use was 3.2% and 7.6% in these groups. Patients in the MeMO program had a decreased risk to discontinue medication of 51% (95% confidence interval: 34%-63%). Results were not affected by potential confounders. Patient satisfaction with MeMO was very high; one quarter of patients mentioned that they only received information about their medication from their pharmacy. Conclusions: Improving adherence to lipid lowering drugs can be achieved by a proactive pharmaceutical care program. Pharmacists can contribute to optimal use of chronic medication, which is likely to reduce healthcare costs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adherence rate was higher in control group (75.2%) compared to intervention group (63.5%)”
From Interventions to improve adherence among patients prescribed statins for primary prevention of cardiovascular diseases: a systematic review and meta-analysis (2026) · cites this paper as Stuurman-Bieze et al., 2013
In the citing paper
“Five studies 36,42,47,55,56 resulted in lower adherence in intervention groups compared to controls.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adherence with statin therapy in elderly patients with and without acute coronary syndromes
Jackevicius, C. A. (2002) · JAMA · doi:10.1001/jama.288.4.462 · Cited by 1,077
Research works printed but not linked: 35
- Nederlands Huisartsen Genootschap (NHG), 2012, Huisarts Wet, 55, 14
- Nederlands Huisartsen Genootschap (NHG), 2006, Huisarts Wet, 49, 137
- 10.1016/S0140-6736(02)09327-3 · DOI · Paper page
- 10.1056/NEJM199511163332001 · DOI · Paper page
- 10.1016/j.atherosclerosissup.2004.08.027 · DOI · Paper page
- 10.1016/S0140-6736(95)92836-7 · DOI · Paper page
- Herings R, 2002, Chronische Farmacotherapie Voortgezet. Een onderzoek naar de omvang, determinanten en mogelijke economische consequenties van het vroegtijdig afbreken van chronische farmacotherapie
- 10.1016/j.amjmed.2011.12.013 · DOI · Paper page
- 10.1111/j.1742-1241.2007.01630.x · DOI · Paper page
- 10.1001/jama.288.4.455 · DOI · Paper page
- 10.1046/j.1524-4733.2000.36006.x · DOI
- 10.1016/j.cjca.2012.03.018 · DOI
- 10.1093/eurheartj/ehl391 · DOI
- 10.1136/hrt.2006.098053 · DOI
- 10.1093/oxfordjournals.eurheartj.a015165 · DOI
- 10.1001/jama.297.2.177 · DOI · Paper page
- 10.1345/aph.1P281 · DOI · Paper page
- 10.1002/pds.1198 · DOI · Paper page
- 10.2147/PPA.S29353 · DOI
- 10.1001/jama.296.21.joc60162 · DOI · Paper page
- 10.1345/aph.1E027 · DOI
- Cipolle RJ, 2004, Pharmaceutical Care Practice: The Clinician’s Guide
- Stuurman-Bieze AGG, 2010, Pharm Weekbl Sci, 4, 128
- Boven van JFM, 2011, Pharm Weekbl Sci, 5, 160
- 10.1111/j.1365-2125.2009.03400.x · DOI
- 10.18553/jmcp.2009.15.6.476 · DOI
- 10.18553/jmcp.2009.15.9.728 · DOI · Paper page
- 10.1007/s11096-005-7113-8 · DOI
- 10.1002/pds.882 · doi:10.1002/pds.882
- 10.1007/3-540-39949-6_25 · DOI
- 10.1007/s00774-013-0440-2 · DOI
- Vegter S, 2011, Am J Manag Care, 17, 609
- Blom A, 2007, Pharm Weekbl Sci, 1, 156
- 10.1016/S0895-4356(97)00040-1 · DOI · Paper page
- 10.1016/j.jval.2011.08.805 · DOI
Cited by
Fang, R., & Li, X. (2016) · Journal of Clinical Nursing · doi:10.1111/jocn.12988 · Cited by 49
Rakhshanda, S., Briggs, N. E., Rhee, J., Rye, K.-A., Liaw, S.-T., & Jonnagaddala, J. (2026) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwag175 · Cited by 6
Metadata
- Authors
- Stuurman-Bieze, A. G. G., Hiddink, E. G., van Boven, J. F. M., & Vegter, S.
- Affiliations
- West Pharmacy, Emmeloord, Netherlands
- Health Base Foundation, Houten, Netherlands
- Unit of PharmacoEpidemiology & PharmacoEconomics, Department of Pharmacy, University of Groningen, Netherlands
- Venue
- Annals of Pharmacotherapy
- Publisher
- SAGE Publications
- Published
- 2013-11
- Volume
- 47
- Issue
- 11
- Pages
- 1448-1456
- ISSN
- 1060-0280
- 1542-6270
- Cited by
- 30
- References
- 1
- Language
- en
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Proactive Pharmaceutical Care Interventions Improve Patients’ Adherence to Lipid-Lowering Medication. https://app.cochat.ai/papers/10.1177/1060028013501146
- The paper
- Stuurman-Bieze, A. G. G., Hiddink, E. G., van Boven, J. F. M., & Vegter, S. (2013). Proactive Pharmaceutical Care Interventions Improve Patients’ Adherence to Lipid-Lowering Medication. Annals of Pharmacotherapy. https://doi.org/10.1177/1060028013501146
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.